AKT1 and cancer: miRNA-489 can sensitize cancer cells to chemotherapy by disrupting molecular pathways involved in cancer growth (e.g., PI3K/Akt) and inducing apoptosis (Ferragut et al. 2020; Kim and Pak 2020; Schell and Rahman 2021; Paskeh et al. 2021).